The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HIV-1 ELISA Kits Market Research Report 2025
Synopsis
HIV-1 ELISA kits are enzyme-linked immunosorbent assay kits designed for the detection and quantification of antibodies specific to Human Immunodeficiency Virus type 1 (HIV-1) in biological samples. These kits use the ELISA method to detect the presence of antibodies produced by the immune system in response to HIV-1 infection. HIV-1 ELISA kits are integral in diagnosing HIV infections, monitoring disease progression, and screening blood donations for HIV. They provide a sensitive and specific tool for detecting antibodies against HIV-1, aiding in the early detection and management of the virus in clinical settings.
The global HIV-1 ELISA Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The industry trend for HIV-1 ELISA kits is evolving in response to the global HIV epidemic and the need for accurate diagnostic tools. With a focus on early detection and treatment of HIV infections to mitigate transmission and improve patient outcomes, there is a growing demand for reliable and high-quality ELISA kits for HIV-1. Manufacturers are constantly innovating to improve the sensitivity, specificity, and accessibility of these kits, making them essential in healthcare settings worldwide. As diagnostic testing plays a pivotal role in HIV management and prevention strategies, the market for HIV-1 ELISA kits is expected to continue growing.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HIV-1 ELISA Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV-1 ELISA Kits.
The HIV-1 ELISA Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global HIV-1 ELISA Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV-1 ELISA Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MyBioSource
XpressBio
R&D Systems
RayBiotech
Abbexa
Sino Biological
Novus Biologicals
Abnova Corporation
OriGene Technologies
United States Biological
Wuhan Fine Biotech
ACROBiosystems
Krishgen Biosystems
Segment by Type
Anti-HIV-1
HIV-1
Segment by Application
Hospital
Laboratory
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HIV-1 ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HIV-1 ELISA Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
HIV-1 ELISA kits are enzyme-linked immunosorbent assay kits designed for the detection and quantification of antibodies specific to Human Immunodeficiency Virus type 1 (HIV-1) in biological samples. These kits use the ELISA method to detect the presence of antibodies produced by the immune system in response to HIV-1 infection. HIV-1 ELISA kits are integral in diagnosing HIV infections, monitoring disease progression, and screening blood donations for HIV. They provide a sensitive and specific tool for detecting antibodies against HIV-1, aiding in the early detection and management of the virus in clinical settings.
The global HIV-1 ELISA Kits market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The industry trend for HIV-1 ELISA kits is evolving in response to the global HIV epidemic and the need for accurate diagnostic tools. With a focus on early detection and treatment of HIV infections to mitigate transmission and improve patient outcomes, there is a growing demand for reliable and high-quality ELISA kits for HIV-1. Manufacturers are constantly innovating to improve the sensitivity, specificity, and accessibility of these kits, making them essential in healthcare settings worldwide. As diagnostic testing plays a pivotal role in HIV management and prevention strategies, the market for HIV-1 ELISA kits is expected to continue growing.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HIV-1 ELISA Kits, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV-1 ELISA Kits.
The HIV-1 ELISA Kits market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global HIV-1 ELISA Kits market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV-1 ELISA Kits manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MyBioSource
XpressBio
R&D Systems
RayBiotech
Abbexa
Sino Biological
Novus Biologicals
Abnova Corporation
OriGene Technologies
United States Biological
Wuhan Fine Biotech
ACROBiosystems
Krishgen Biosystems
Segment by Type
Anti-HIV-1
HIV-1
Segment by Application
Hospital
Laboratory
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HIV-1 ELISA Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HIV-1 ELISA Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 HIV-1 ELISA Kits Market Overview
1.1 Product Definition
1.2 HIV-1 ELISA Kits by Type
1.2.1 Global HIV-1 ELISA Kits Market Value Comparison by Type (2024-2030)
1.2.2 Anti-HIV-1
1.2.3 HIV-1
1.3 HIV-1 ELISA Kits by Application
1.3.1 Global HIV-1 ELISA Kits Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Global HIV-1 ELISA Kits Market Size Estimates and Forecasts
1.4.1 Global HIV-1 ELISA Kits Revenue 2019-2030
1.4.2 Global HIV-1 ELISA Kits Sales 2019-2030
1.4.3 Global HIV-1 ELISA Kits Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 HIV-1 ELISA Kits Market Competition by Manufacturers
2.1 Global HIV-1 ELISA Kits Sales Market Share by Manufacturers (2019-2024)
2.2 Global HIV-1 ELISA Kits Revenue Market Share by Manufacturers (2019-2024)
2.3 Global HIV-1 ELISA Kits Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of HIV-1 ELISA Kits, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HIV-1 ELISA Kits, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HIV-1 ELISA Kits, Product Type & Application
2.7 Global Key Manufacturers of HIV-1 ELISA Kits, Date of Enter into This Industry
2.8 Global HIV-1 ELISA Kits Market Competitive Situation and Trends
2.8.1 Global HIV-1 ELISA Kits Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HIV-1 ELISA Kits Players Market Share by Revenue
2.8.3 Global HIV-1 ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HIV-1 ELISA Kits Market Scenario by Region
3.1 Global HIV-1 ELISA Kits Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global HIV-1 ELISA Kits Sales by Region: 2019-2030
3.2.1 Global HIV-1 ELISA Kits Sales by Region: 2019-2024
3.2.2 Global HIV-1 ELISA Kits Sales by Region: 2025-2030
3.3 Global HIV-1 ELISA Kits Revenue by Region: 2019-2030
3.3.1 Global HIV-1 ELISA Kits Revenue by Region: 2019-2024
3.3.2 Global HIV-1 ELISA Kits Revenue by Region: 2025-2030
3.4 North America HIV-1 ELISA Kits Market Facts & Figures by Country
3.4.1 North America HIV-1 ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America HIV-1 ELISA Kits Sales by Country (2019-2030)
3.4.3 North America HIV-1 ELISA Kits Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe HIV-1 ELISA Kits Market Facts & Figures by Country
3.5.1 Europe HIV-1 ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe HIV-1 ELISA Kits Sales by Country (2019-2030)
3.5.3 Europe HIV-1 ELISA Kits Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HIV-1 ELISA Kits Market Facts & Figures by Region
3.6.1 Asia Pacific HIV-1 ELISA Kits Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific HIV-1 ELISA Kits Sales by Region (2019-2030)
3.6.3 Asia Pacific HIV-1 ELISA Kits Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HIV-1 ELISA Kits Market Facts & Figures by Country
3.7.1 Latin America HIV-1 ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America HIV-1 ELISA Kits Sales by Country (2019-2030)
3.7.3 Latin America HIV-1 ELISA Kits Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HIV-1 ELISA Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa HIV-1 ELISA Kits Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa HIV-1 ELISA Kits Sales by Country (2019-2030)
3.8.3 Middle East and Africa HIV-1 ELISA Kits Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HIV-1 ELISA Kits Sales by Type (2019-2030)
4.1.1 Global HIV-1 ELISA Kits Sales by Type (2019-2024)
4.1.2 Global HIV-1 ELISA Kits Sales by Type (2025-2030)
4.1.3 Global HIV-1 ELISA Kits Sales Market Share by Type (2019-2030)
4.2 Global HIV-1 ELISA Kits Revenue by Type (2019-2030)
4.2.1 Global HIV-1 ELISA Kits Revenue by Type (2019-2024)
4.2.2 Global HIV-1 ELISA Kits Revenue by Type (2025-2030)
4.2.3 Global HIV-1 ELISA Kits Revenue Market Share by Type (2019-2030)
4.3 Global HIV-1 ELISA Kits Price by Type (2019-2030)
5 Segment by Application
5.1 Global HIV-1 ELISA Kits Sales by Application (2019-2030)
5.1.1 Global HIV-1 ELISA Kits Sales by Application (2019-2024)
5.1.2 Global HIV-1 ELISA Kits Sales by Application (2025-2030)
5.1.3 Global HIV-1 ELISA Kits Sales Market Share by Application (2019-2030)
5.2 Global HIV-1 ELISA Kits Revenue by Application (2019-2030)
5.2.1 Global HIV-1 ELISA Kits Revenue by Application (2019-2024)
5.2.2 Global HIV-1 ELISA Kits Revenue by Application (2025-2030)
5.2.3 Global HIV-1 ELISA Kits Revenue Market Share by Application (2019-2030)
5.3 Global HIV-1 ELISA Kits Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MyBioSource
6.1.1 MyBioSource Company Information
6.1.2 MyBioSource Description and Business Overview
6.1.3 MyBioSource HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MyBioSource HIV-1 ELISA Kits Product Portfolio
6.1.5 MyBioSource Recent Developments/Updates
6.2 XpressBio
6.2.1 XpressBio Company Information
6.2.2 XpressBio Description and Business Overview
6.2.3 XpressBio HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.2.4 XpressBio HIV-1 ELISA Kits Product Portfolio
6.2.5 XpressBio Recent Developments/Updates
6.3 R&D Systems
6.3.1 R&D Systems Company Information
6.3.2 R&D Systems Description and Business Overview
6.3.3 R&D Systems HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.3.4 R&D Systems HIV-1 ELISA Kits Product Portfolio
6.3.5 R&D Systems Recent Developments/Updates
6.4 RayBiotech
6.4.1 RayBiotech Company Information
6.4.2 RayBiotech Description and Business Overview
6.4.3 RayBiotech HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.4.4 RayBiotech HIV-1 ELISA Kits Product Portfolio
6.4.5 RayBiotech Recent Developments/Updates
6.5 Abbexa
6.5.1 Abbexa Company Information
6.5.2 Abbexa Description and Business Overview
6.5.3 Abbexa HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abbexa HIV-1 ELISA Kits Product Portfolio
6.5.5 Abbexa Recent Developments/Updates
6.6 Sino Biological
6.6.1 Sino Biological Company Information
6.6.2 Sino Biological Description and Business Overview
6.6.3 Sino Biological HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sino Biological HIV-1 ELISA Kits Product Portfolio
6.6.5 Sino Biological Recent Developments/Updates
6.7 Novus Biologicals
6.7.1 Novus Biologicals Company Information
6.7.2 Novus Biologicals Description and Business Overview
6.7.3 Novus Biologicals HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Novus Biologicals HIV-1 ELISA Kits Product Portfolio
6.7.5 Novus Biologicals Recent Developments/Updates
6.8 Abnova Corporation
6.8.1 Abnova Corporation Company Information
6.8.2 Abnova Corporation Description and Business Overview
6.8.3 Abnova Corporation HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abnova Corporation HIV-1 ELISA Kits Product Portfolio
6.8.5 Abnova Corporation Recent Developments/Updates
6.9 OriGene Technologies
6.9.1 OriGene Technologies Company Information
6.9.2 OriGene Technologies Description and Business Overview
6.9.3 OriGene Technologies HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.9.4 OriGene Technologies HIV-1 ELISA Kits Product Portfolio
6.9.5 OriGene Technologies Recent Developments/Updates
6.10 United States Biological
6.10.1 United States Biological Company Information
6.10.2 United States Biological Description and Business Overview
6.10.3 United States Biological HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.10.4 United States Biological HIV-1 ELISA Kits Product Portfolio
6.10.5 United States Biological Recent Developments/Updates
6.11 Wuhan Fine Biotech
6.11.1 Wuhan Fine Biotech Company Information
6.11.2 Wuhan Fine Biotech Description and Business Overview
6.11.3 Wuhan Fine Biotech HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Wuhan Fine Biotech HIV-1 ELISA Kits Product Portfolio
6.11.5 Wuhan Fine Biotech Recent Developments/Updates
6.12 ACROBiosystems
6.12.1 ACROBiosystems Company Information
6.12.2 ACROBiosystems Description and Business Overview
6.12.3 ACROBiosystems HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ACROBiosystems HIV-1 ELISA Kits Product Portfolio
6.12.5 ACROBiosystems Recent Developments/Updates
6.13 Krishgen Biosystems
6.13.1 Krishgen Biosystems Company Information
6.13.2 Krishgen Biosystems Description and Business Overview
6.13.3 Krishgen Biosystems HIV-1 ELISA Kits Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Krishgen Biosystems HIV-1 ELISA Kits Product Portfolio
6.13.5 Krishgen Biosystems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HIV-1 ELISA Kits Industry Chain Analysis
7.2 HIV-1 ELISA Kits Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HIV-1 ELISA Kits Production Mode & Process
7.4 HIV-1 ELISA Kits Sales and Marketing
7.4.1 HIV-1 ELISA Kits Sales Channels
7.4.2 HIV-1 ELISA Kits Distributors
7.5 HIV-1 ELISA Kits Customers
8 HIV-1 ELISA Kits Market Dynamics
8.1 HIV-1 ELISA Kits Industry Trends
8.2 HIV-1 ELISA Kits Market Drivers
8.3 HIV-1 ELISA Kits Market Challenges
8.4 HIV-1 ELISA Kits Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global HIV-1 ELISA Kits Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global HIV-1 ELISA Kits Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global HIV-1 ELISA Kits Market Competitive Situation by Manufacturers in 2023
Table 4. Global HIV-1 ELISA Kits Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global HIV-1 ELISA Kits Sales Market Share by Manufacturers (2019-2024)
Table 6. Global HIV-1 ELISA Kits Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global HIV-1 ELISA Kits Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market HIV-1 ELISA Kits Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of HIV-1 ELISA Kits, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of HIV-1 ELISA Kits, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of HIV-1 ELISA Kits, Product Type & Application
Table 12. Global Key Manufacturers of HIV-1 ELISA Kits, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global HIV-1 ELISA Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-1 ELISA Kits as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global HIV-1 ELISA Kits Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global HIV-1 ELISA Kits Sales by Region (2019-2024) & (K Units)
Table 18. Global HIV-1 ELISA Kits Sales Market Share by Region (2019-2024)
Table 19. Global HIV-1 ELISA Kits Sales by Region (2025-2030) & (K Units)
Table 20. Global HIV-1 ELISA Kits Sales Market Share by Region (2025-2030)
Table 21. Global HIV-1 ELISA Kits Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global HIV-1 ELISA Kits Revenue Market Share by Region (2019-2024)
Table 23. Global HIV-1 ELISA Kits Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global HIV-1 ELISA Kits Revenue Market Share by Region (2025-2030)
Table 25. North America HIV-1 ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America HIV-1 ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 27. North America HIV-1 ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 28. North America HIV-1 ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America HIV-1 ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe HIV-1 ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe HIV-1 ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 32. Europe HIV-1 ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 33. Europe HIV-1 ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe HIV-1 ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific HIV-1 ELISA Kits Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific HIV-1 ELISA Kits Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific HIV-1 ELISA Kits Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific HIV-1 ELISA Kits Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific HIV-1 ELISA Kits Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America HIV-1 ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America HIV-1 ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 42. Latin America HIV-1 ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 43. Latin America HIV-1 ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America HIV-1 ELISA Kits Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa HIV-1 ELISA Kits Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa HIV-1 ELISA Kits Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa HIV-1 ELISA Kits Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa HIV-1 ELISA Kits Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa HIV-1 ELISA Kits Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global HIV-1 ELISA Kits Sales (K Units) by Type (2019-2024)
Table 51. Global HIV-1 ELISA Kits Sales (K Units) by Type (2025-2030)
Table 52. Global HIV-1 ELISA Kits Sales Market Share by Type (2019-2024)
Table 53. Global HIV-1 ELISA Kits Sales Market Share by Type (2025-2030)
Table 54. Global HIV-1 ELISA Kits Revenue (US$ Million) by Type (2019-2024)
Table 55. Global HIV-1 ELISA Kits Revenue (US$ Million) by Type (2025-2030)
Table 56. Global HIV-1 ELISA Kits Revenue Market Share by Type (2019-2024)
Table 57. Global HIV-1 ELISA Kits Revenue Market Share by Type (2025-2030)
Table 58. Global HIV-1 ELISA Kits Price (US$/Unit) by Type (2019-2024)
Table 59. Global HIV-1 ELISA Kits Price (US$/Unit) by Type (2025-2030)
Table 60. Global HIV-1 ELISA Kits Sales (K Units) by Application (2019-2024)
Table 61. Global HIV-1 ELISA Kits Sales (K Units) by Application (2025-2030)
Table 62. Global HIV-1 ELISA Kits Sales Market Share by Application (2019-2024)
Table 63. Global HIV-1 ELISA Kits Sales Market Share by Application (2025-2030)
Table 64. Global HIV-1 ELISA Kits Revenue (US$ Million) by Application (2019-2024)
Table 65. Global HIV-1 ELISA Kits Revenue (US$ Million) by Application (2025-2030)
Table 66. Global HIV-1 ELISA Kits Revenue Market Share by Application (2019-2024)
Table 67. Global HIV-1 ELISA Kits Revenue Market Share by Application (2025-2030)
Table 68. Global HIV-1 ELISA Kits Price (US$/Unit) by Application (2019-2024)
Table 69. Global HIV-1 ELISA Kits Price (US$/Unit) by Application (2025-2030)
Table 70. MyBioSource Company Information
Table 71. MyBioSource Description and Business Overview
Table 72. MyBioSource HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. MyBioSource HIV-1 ELISA Kits Product
Table 74. MyBioSource Recent Developments/Updates
Table 75. XpressBio Company Information
Table 76. XpressBio Description and Business Overview
Table 77. XpressBio HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. XpressBio HIV-1 ELISA Kits Product
Table 79. XpressBio Recent Developments/Updates
Table 80. R&D Systems Company Information
Table 81. R&D Systems Description and Business Overview
Table 82. R&D Systems HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. R&D Systems HIV-1 ELISA Kits Product
Table 84. R&D Systems Recent Developments/Updates
Table 85. RayBiotech Company Information
Table 86. RayBiotech Description and Business Overview
Table 87. RayBiotech HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. RayBiotech HIV-1 ELISA Kits Product
Table 89. RayBiotech Recent Developments/Updates
Table 90. Abbexa Company Information
Table 91. Abbexa Description and Business Overview
Table 92. Abbexa HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Abbexa HIV-1 ELISA Kits Product
Table 94. Abbexa Recent Developments/Updates
Table 95. Sino Biological Company Information
Table 96. Sino Biological Description and Business Overview
Table 97. Sino Biological HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sino Biological HIV-1 ELISA Kits Product
Table 99. Sino Biological Recent Developments/Updates
Table 100. Novus Biologicals Company Information
Table 101. Novus Biologicals Description and Business Overview
Table 102. Novus Biologicals HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Novus Biologicals HIV-1 ELISA Kits Product
Table 104. Novus Biologicals Recent Developments/Updates
Table 105. Abnova Corporation Company Information
Table 106. Abnova Corporation Description and Business Overview
Table 107. Abnova Corporation HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Abnova Corporation HIV-1 ELISA Kits Product
Table 109. Abnova Corporation Recent Developments/Updates
Table 110. OriGene Technologies Company Information
Table 111. OriGene Technologies Description and Business Overview
Table 112. OriGene Technologies HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. OriGene Technologies HIV-1 ELISA Kits Product
Table 114. OriGene Technologies Recent Developments/Updates
Table 115. United States Biological Company Information
Table 116. United States Biological Description and Business Overview
Table 117. United States Biological HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. United States Biological HIV-1 ELISA Kits Product
Table 119. United States Biological Recent Developments/Updates
Table 120. Wuhan Fine Biotech Company Information
Table 121. Wuhan Fine Biotech Description and Business Overview
Table 122. Wuhan Fine Biotech HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Wuhan Fine Biotech HIV-1 ELISA Kits Product
Table 124. Wuhan Fine Biotech Recent Developments/Updates
Table 125. ACROBiosystems Company Information
Table 126. ACROBiosystems Description and Business Overview
Table 127. ACROBiosystems HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. ACROBiosystems HIV-1 ELISA Kits Product
Table 129. ACROBiosystems Recent Developments/Updates
Table 130. Krishgen Biosystems Company Information
Table 131. Krishgen Biosystems Description and Business Overview
Table 132. Krishgen Biosystems HIV-1 ELISA Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Krishgen Biosystems HIV-1 ELISA Kits Product
Table 134. Krishgen Biosystems Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. HIV-1 ELISA Kits Distributors List
Table 138. HIV-1 ELISA Kits Customers List
Table 139. HIV-1 ELISA Kits Market Trends
Table 140. HIV-1 ELISA Kits Market Drivers
Table 141. HIV-1 ELISA Kits Market Challenges
Table 142. HIV-1 ELISA Kits Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of HIV-1 ELISA Kits
Figure 2. Global HIV-1 ELISA Kits Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global HIV-1 ELISA Kits Market Share by Type: 2023 & 2030
Figure 4. Anti-HIV-1 Product Picture
Figure 5. HIV-1 Product Picture
Figure 6. Global HIV-1 ELISA Kits Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global HIV-1 ELISA Kits Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Laboratory
Figure 10. Others
Figure 11. Global HIV-1 ELISA Kits Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global HIV-1 ELISA Kits Market Size (2019-2030) & (US$ Million)
Figure 13. Global HIV-1 ELISA Kits Sales (2019-2030) & (K Units)
Figure 14. Global HIV-1 ELISA Kits Average Price (US$/Unit) & (2019-2030)
Figure 15. HIV-1 ELISA Kits Report Years Considered
Figure 16. HIV-1 ELISA Kits Sales Share by Manufacturers in 2023
Figure 17. Global HIV-1 ELISA Kits Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest HIV-1 ELISA Kits Players: Market Share by Revenue in HIV-1 ELISA Kits in 2023
Figure 19. HIV-1 ELISA Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global HIV-1 ELISA Kits Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America HIV-1 ELISA Kits Sales Market Share by Country (2019-2030)
Figure 22. North America HIV-1 ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 23. United States HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe HIV-1 ELISA Kits Sales Market Share by Country (2019-2030)
Figure 26. Europe HIV-1 ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 27. Germany HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific HIV-1 ELISA Kits Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific HIV-1 ELISA Kits Revenue Market Share by Region (2019-2030)
Figure 34. China HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America HIV-1 ELISA Kits Sales Market Share by Country (2019-2030)
Figure 42. Mexico HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa HIV-1 ELISA Kits Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa HIV-1 ELISA Kits Revenue Market Share by Country (2019-2030)
Figure 48. Turkey HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE HIV-1 ELISA Kits Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of HIV-1 ELISA Kits by Type (2019-2030)
Figure 52. Global Revenue Market Share of HIV-1 ELISA Kits by Type (2019-2030)
Figure 53. Global HIV-1 ELISA Kits Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of HIV-1 ELISA Kits by Application (2019-2030)
Figure 55. Global Revenue Market Share of HIV-1 ELISA Kits by Application (2019-2030)
Figure 56. Global HIV-1 ELISA Kits Price (US$/Unit) by Application (2019-2030)
Figure 57. HIV-1 ELISA Kits Value Chain
Figure 58. HIV-1 ELISA Kits Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
